MCNEIL ARTHRITIS FOUNDATION PAIN RELIEVER LINE
This article was originally published in The Tan Sheet
Executive Summary
MCNEIL ARTHRITIS FOUNDATION PAIN RELIEVER LINE of four products is expected to reach store shelves nationwide in early October, according to a July 7 joint announcement by McNeil Consumer Products and the Arthritis Foundation. The line, which bears the name of the Arthritis Foundation and is being developed under a partnership between McNeil and the health group, includes two acetaminophen products, an enteric-coated aspirin product and an ibuprofen-based product. In March, McNeil received ANDA approval for ibuprofen 200 mg tablets.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning